How a Heart Attack Is Treated

Table of Contents
View All
Table of Contents

Treatment of an acute heart attack (myocardial infarction, MI) must be prompt and comprehensive. Medical therapy is used to stabilize the cardiovascular system and prevent or minimize long-term complications. This may include angioplasty and the use of thrombolytics or other priority medications for a heart attack.

Heart attacks need to be urgently treated because blockage of coronary arteries that supply blood to the heart causes an area of the heart muscle to begin to die—and longer blood flow insufficiency means more damage.

Doctor trying to rescue they patient
Antonio_Diaz / Getty Images

Call 911 immediately if you are having signs of a heart attack. Do not drive yourself to the hospital. You could lose consciousness while driving and get into an accident.

Immediate Priorities

The first few hours after a heart attack are critical. Getting medical help as rapidly as possible is essential to preventing cardiac arrest, preserving heart muscle, and preventing further blood clots from forming. National guidelines recommend that the affected coronary artery be opened within 90 minutes for the best outcome.

If you arrive at the hospital with a possible heart attack, medical personnel will immediately check your vital signs (pulse and blood pressure) and prepare to deal with any apparent life-threatening conditions, such as ventricular fibrillation.

An electrocardiogram (ECG) and cardiac enzyme testing will also be performed. High-sensitivity cardiac troponin levels will likely be checked—they are the preferred biomarker fot myocardial injury (cardiac cell damage).

Treatment is started once a heart attack is suspected.

This can include:

  • Aspirin is given to prevent further blood clotting
  • Oxygen therapy
  • Nitroglycerine to improve blood flow
  • Chest pain treatment

Your healthcare team will also determine which type of heart attack has occurred:

Based on the diagnosis, the medical team will start treatment to restore blood flow through the blocked or partially blocked blood vessels. This may include a procedure or medications.

Both surgery and medication can be highly effective if given early enough, and the method chosen should usually be whichever is likely to open the artery faster.


In the event of a STEMI or NSTEMI, immediate steps must be taken to unblock the artery, get blood flowing through it again as quickly as possible, and prevent damage.

One main treatment is a non-surgical procedure called coronary angioplasty, also called percutaneous coronary intervention (PCI). A thin tube with a balloon is threaded through a blood vessel to the blocked artery. The balloon is then inflated to push the clot against the artery wall to restore blood flow. A stent may be placed to keep the blood vessel open after the procedure.

With partially blocked blood vessels, PCI can also be beneficial, depending on the level of severity. About 32% to 40% of patients with NSTE acute coronary syndromes will have a PCI done at the hospital.

Coronary artery bypass grafting (CABG) may be considered for patients who are not candidates for PCI or who have cardiogenic shock. During this surgery, a healthy vein in your body is removed from elsewhere In the body and then re-connected in the affected area to bypass the blocked section and restore blood flow to the heart.


There are many medications that can be used during and immediately after a heart attack to stop the event and help prevent further damage to the heart.

Thrombolytic Therapy

This approach to treating an acute heart attack involves using medication to break up a blood clot. These powerful drugs, also known as thrombolytics or fibrinolytic agents, are only given in the event of a STEMI. They are given intravenously and nicknamed "clot busters" because they do just that—dissolve blood clots that are in the process of forming. 

Thrombolytic therapy is most likely to be used for STEMI patients if angioplasty can't be performed or isn't a safe option. The best results are obtained if the medication is given as soon as possible after chest pain occurs, usually in less than 12 hours.

Tissue plasminogen activator (tPA) is the type of thrombolytic most often used to break up a blood clot during a heart attack.

The major side effect of thrombolytic therapy is bleeding, making it unsafe for patients at high risk of this complication, such as those who've had recent surgery, have a history of stroke due to brain hemorrhage, or have very high blood pressure.


Aspirin is the most commonly used antiplatelet. It reduces the stickiness of platelets, thereby making it difficult for blood clots to form or get bigger.

One-half or one whole uncoated adult aspirin, chewed or crushed, taken as soon as possible when a heart attack (or any acute coronary syndrome event) is suspected can significantly improve outcomes.

Heart attack patients are often treated with dual antiplatelet therapy, meaning that two types of antiplatelet agents are taken to prevent blood clotting. In addition to aspirin, your healthcare provider would prescribe a P2Y12 inhibitor such as clopidogrel, prasugrel, or ticagrelor.

You should discuss with your healthcare provider whether dual antiplatelet therapy is the right treatment for you.


Anticoagulants slow down your body’s ability to make clots. Given within the first 24 hours of an acute heart attack, these blood thinners help prevent clotting in your arteries and may lower the risk of long-term mortality.

These drugs include:

  • Heparin
  • Coumadin (warfarin)
  • Eliquis (apixaban)
  • Xarelto (rivaroxaban)

Eliquis, Xarelto, and like drugs are sometimes referred to as novel oral anticoagulants (NOACs).


Beta-blockers significantly improve the survival of patients with MIs. These drugs are typically recommended beginning on the first day after a heart attack.

According to the American Heart Association, the beta-blockers most often prescribed after a heart attack are:

  • Lopressor, Toprol XL (metoprolol)
  • Corgard (nadolol)
  • Inderal (propranolol)
  • Sectral (acebutolol)
  • Tenormin (atenolol)
  • Kerlone (betaxolol)
  • Ziac (bisoprolol/hydrochlorothiazide)
  • Zebeta (Bisoprolol)
  • Betapace (sotalol)

Angiotensin-Converting Enzyme (ACE) Inhibitors

These drugs expand blood vessels and allow blood to flow more easily. ACE inhibitors have been shown to significantly improve the outcome of patients who have significant heart attacks or signs of heart failure, although they also can be beneficial in patients with less severe heart attacks.

ACE inhibitors are usually started during the first 24 hours after a heart attack.

Examples include:

  • Lotensin (benazepril)
  • Vasotec (enalapril)
  • Altace (ramipril)


Statins appear to improve survival after a heart attack regardless of cholesterol levels, probably by reducing inflammation or stabilizing coronary artery plaques in some other way.

Most often, statins should be started before a heart attack patient leaves the hospital. Sometimes it's beneficial to begin them even sooner.

The primary statins are:

  • Lipitor (atorvastatin)
  • Lescol (fluvastatin)
  • Mevacor (lovastatin)
  • Livalo (pitavastatin)
  • Pravachol (pravastatin)
  • Zocor (simvastatin)
  • Crestor (rosuvastatin)

A Word From Verywell

Surviving a heart attack requires ongoing effort after that first critical day. Your healthcare provider will work with you to determine the steps that need to be taken to prevent complications and another event.

Frequently Asked Questions

  • What should I do if I have a heart attack while I'm alone?

    Call 9-1-1 immediately—do not attempt to drive yourself to the emergency room. While you wait for help:

    • Call a family member or friend to wait with you.
    • If you've been prescribed nitroglycerin, take it as directed.
    • Whether you have nitroglycerin or not, take 325 milligrams (mg) of aspirin. It will work faster if you chew the tablet rather than swallow it whole.
    • Make sure your door is unlocked so the emergency team and friend or family member can get in.
    • Wrap up in a blanket to stay warm.
    • Sit comfortably propped up and try to stay calm.
  • Are heart attacks always fatal?

    No. In fact, around 80% of people who have an acute myocardial infarction survive beyond a year. Those who don't survive tend to have certain risk factors, such as a previous heart attack and a chronic condition such as diabetes, liver disease, or cancer.

  • Why do women put off getting treatment for heart attacks?

    Females wait an average of 37 minutes longer than males to seek medical attention for a heart attack. Studies show they're likely to delay getting help because they don't recognize their symptoms as indicating a heart attack. Women do not always have chest pain with a heart attack and may have other symptoms, including trouble breathing, jaw pain, stomach pain, indigestion, and back pain—all of which contribute to delayed recognition. Women sometimes also choose to wait to see if their symptoms go away or put up with the discomfort.

  • How much does heart attack treatment cost?

    According to a review of 114 studies, in the United States, the average cost for treatment for a heart attack can range from around $17,000 to $30,000. Of course, how much a patient may actually have to pay will depend on their health insurance (if they have it), and other factors.

21 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Park J, Choi KH, Lee JM, et al. Prognostic implications of door‐to‐balloon time and onset‐to‐door time on mortality in patients with ST‐segment–elevation myocardial infarction treated with primary percutaneous coronary intervention. JAHA. 2019;8(9):e012188. doi:10.1161/JAHA.119.012188

  2. Gulati M, Levy PD, Mukherjee D, et al. 2021AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesCirculation. 2021;144(22). doi:10.1161/CIR.0000000000001029

  3. National Heart, Lung, and Blood Institute. Heart attack

  4. Smith J, Negrelli J, Manek M, Hawes E, Viera A. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015;28(2):283-293. doi:10.3122/jabfm.2015.02.140189

  5. Amsterdam E, Wenger N, Brindis R et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes. Circulation. 2014;130(25). doi:10.1161/cir.0000000000000134

  6. O’Gara P, Kushner F, Ascheim D et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Circulation. 2013;127(4). doi:10.1161/cir.0b013e3182742cf6

  7. MedlinePlus. Thrombolytic drugs for heart attack.

  8. Ali MR, Salim Hossain M, Islam MA, et al. Aspect of thrombolytic therapy: a reviewScientificWorldJournal. 2014;2014:586510. doi:10.1155/2014/586510

  9. MedlinePlus. Thrombolytic therapy.

  10. Patel MD, Wu D, Chase MR, et al. Antiplatelet therapy and clinical outcomes following myocardial infarction among patients in a U.S. employer-based insurance database. J Manag Care Spec Pharm. 2017;23(6):684-690. doi:10.18553/jmcp.2017.23.6.684

  11. MedlinePlus. Blood thinners.

  12. American Heart Association. Cardiac medications.

  13. Gillette M, Morneau K, Hoang V, Virani S, Jneid H. Antiplatelet management for coronary heart disease: advances and challenges. Curr Atheroscler Rep. 2016;18(6):35. doi:10.1007/s11883-016-0581-6

  14. Han X, Zhang Y, Yin L, et al. Statin in the treatment of patients with myocardial infarction: A meta-analysisMedicine (Baltimore). 2018;97(12):e0167. doi:10.1097/MD.0000000000010167

  15. American Heart Association. Warning signs of a heart attack.

  16. MedlinePlus. Nitroglycerin sublingual.

  17. Harvard Health Publishing. Harvard Medical School. Aspirin for heart attack? Chew or swallow?

  18. Ye Q, Zhang J, Ma L. Predictors of all-cause 1-year mortality in myocardial infarction patientsMedicine (Baltimore). 2020;99(29):e21288. doi:10.1097/MD.0000000000021288

  19. American College of Cardiology. Women wait longer to seek treatment for heart attack, study finds.

  20. Taghaddosi M, Dianati M, Fath Gharib Bidgoli J, et al. Delay and its related factors in seeking treatment in patients with acute myocardial infarctionARYA Atheroscler. 2010;6(1):35-41.

  21. Nicholson G, Gandra SR, Halbert RJ, et al. Patient-level costs of major cardiovascular conditions: a review of the international literatureClinicoecon Outcomes Res. 2016;8:495-506. doi:10.2147/CEOR.S89331

Additional Reading

By Richard N. Fogoros, MD
Richard N. Fogoros, MD, is a retired professor of medicine and board-certified in internal medicine, clinical cardiology, and clinical electrophysiology.